Ching-Hon Pui, MD, discusses the use of CAR T-cell therapy in patients with relapsed/refractory acute lymphocytic leukemia.
Ching-Hon Pui, MD
Advertisement
Articles by Ching-Hon Pui, MD
Advertisement
Latest Updated Articles
Dr. Pui on Utilizing CAR T-Cell Therapy in Pediatric ALLPublished: September 14th 2019 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
PreBLA Meeting With FDA Sinks uniQure’s Hopes for Approval of Huntington Disease Gene Therapy AMT-130 Based Primarily on Phase 1/2 Data
2
FDA Activity Recap: October 2025 Features New Platform Technology Designation, RDEA Pilot Program Selection, and More
3
